Recruiting
Toronto Gestational Glucose Tolerance Cohort
In this prospective observational cohort study, women representing the full spectrum of gestational glucose tolerance status are undergoing longitudinal cardiometabolic characterization at regular intervals in the years after the index pregnancy.
ClinicalTrials.gov IDNCT02583061
PhaseNot Applicable
Enrollment350
SponsorMount Sinai Hospital, Canada
Age20 Years
SexFEMALE
Conditions studied
Type 2 Diabetes, Gestational Diabetes, Pre-diabetes
About this study
In this prospective observational cohort study, women representing the full spectrum of gestational glucose tolerance status are undergoing longitudinal cardiometabolic characterization at regular intervals in the years after the index pregnancy.
Interventions
- Other: There is no intervention. An exposure of interest is glucose tolerance status in pregnancy
Primary outcomes
- Glucose tolerance status (10 years after pregnancy)
Eligibility information
Inclusion Criteria:
* Pregnant women
Exclusion Criteria:
* Pre-existing diabetes before the index pregnancy
Study locations
- Mount Sinai Hospital, Toronto, Ontario M5G1X5 Canada
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.